rs61735825

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_006031.6(PCNT):​c.467A>G​(p.His156Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 139,726 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H156Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0062 ( 62 hom. )
Failed GnomAD Quality Control

Consequence

PCNT
NM_006031.6 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.595

Publications

12 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003022194).
BP6
Variant 21-46334596-A-G is Benign according to our data. Variant chr21-46334596-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 159608.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.467A>G p.His156Arg missense_variant Exon 3 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.113A>G p.His38Arg missense_variant Exon 3 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.467A>G p.His156Arg missense_variant Exon 3 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
194
AN:
139612
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00151
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000425
Gnomad ASJ
AF:
0.000905
Gnomad EAS
AF:
0.000588
Gnomad SAS
AF:
0.000427
Gnomad FIN
AF:
0.000696
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00184
Gnomad OTH
AF:
0.00156
GnomAD2 exomes
AF:
0.00138
AC:
330
AN:
238690
AF XY:
0.00130
show subpopulations
Gnomad AFR exome
AF:
0.000636
Gnomad AMR exome
AF:
0.000632
Gnomad ASJ exome
AF:
0.000926
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.000812
Gnomad NFE exome
AF:
0.00241
Gnomad OTH exome
AF:
0.00206
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00617
AC:
8203
AN:
1330044
Hom.:
62
Cov.:
32
AF XY:
0.00580
AC XY:
3846
AN XY:
663618
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00148
AC:
48
AN:
32382
American (AMR)
AF:
0.00374
AC:
159
AN:
42546
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
57
AN:
24684
East Asian (EAS)
AF:
0.000329
AC:
13
AN:
39496
South Asian (SAS)
AF:
0.000445
AC:
38
AN:
85328
European-Finnish (FIN)
AF:
0.00138
AC:
70
AN:
50892
Middle Eastern (MID)
AF:
0.000888
AC:
5
AN:
5632
European-Non Finnish (NFE)
AF:
0.00762
AC:
7568
AN:
993640
Other (OTH)
AF:
0.00442
AC:
245
AN:
55444
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.269
Heterozygous variant carriers
0
900
1799
2699
3598
4498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00140
AC:
195
AN:
139726
Hom.:
1
Cov.:
33
AF XY:
0.00131
AC XY:
90
AN XY:
68688
show subpopulations
African (AFR)
AF:
0.00156
AC:
61
AN:
39128
American (AMR)
AF:
0.000425
AC:
6
AN:
14134
Ashkenazi Jewish (ASJ)
AF:
0.000905
AC:
3
AN:
3314
East Asian (EAS)
AF:
0.000393
AC:
2
AN:
5086
South Asian (SAS)
AF:
0.000428
AC:
2
AN:
4676
European-Finnish (FIN)
AF:
0.000696
AC:
7
AN:
10054
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00184
AC:
111
AN:
60208
Other (OTH)
AF:
0.00154
AC:
3
AN:
1948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0456
Hom.:
58
Bravo
AF:
0.0376
TwinsUK
AF:
0.0467
AC:
173
ALSPAC
AF:
0.0488
AC:
188
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.0370
AC:
318
ExAC
AF:
0.000556
AC:
67

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 19, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 12, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Microcephalic osteodysplastic primordial dwarfism type II Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Benign:1
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.23
DANN
Benign
0.31
DEOGEN2
Benign
0.016
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.00062
N
LIST_S2
Benign
0.15
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.69
N
PhyloP100
-0.59
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.030
N
REVEL
Benign
0.023
Sift
Benign
0.45
T
Sift4G
Benign
0.44
T
Polyphen
0.0
B
Vest4
0.084
MVP
0.20
MPC
0.099
ClinPred
0.0013
T
GERP RS
0.16
Varity_R
0.025
gMVP
0.015
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735825; hg19: chr21-47754510; COSMIC: COSV64028541; API